AZAbzal Zhumagaliuly

Abzal Zhumagaliuly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abzal Zhumagaliuly has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Refinement of a scoping tool to tackle antimicrobial resistance via a primary health care approach: insights from Kazakhstan, Sweden, and Thailand

    by Serena W Y Chong, Sarah Paulin, Faraz Khalid, Stephan Stenmark, Danilo Lo Fo Wong, Deborah Tong, Ketevan Kandelaki, Viroj Tangcharoensathien, Bassem Zayed, Abzal Zhumagaliuly, et al.

  • Open Access

    Prevalence and Factors Associated with Insomnia Among Healthcare Workers in Kazakhstan During the COVID-19 Pandemic: A Cross-Sectional Study

    by Nurila Aryntayeva, Kuanysh Shonbay, Tulay Koru-Sengul, Fatima Bagiyarova, Gulshara Aimbetova, Guoyan Zhang, Saltanat Umbetkulova, Abzal Zhumagaliuly, Venera Baisugurova, Indira Karibayeva

    Background and Objectives: Healthcare workers (HCWs) involved in the COVID-19 response are at increased risk of mental health disturbances, including sleep disorders. This study aimed to assess the prevalence and predictors of insomnia among HCWs in Almaty, Kazakhstan. Materials and Methods: A cross-sectional study was conducted between 11 and 26 September 2021, including 553 HCWs. Insomnia symptoms were assessed using the Insomnia Severity Index (ISI). The primary binary outcome was defined as an ISI score ≥ 10, while ISI ≥ 15 was used descriptively to indicate moderate-to-severe insomnia symptoms. Associations were evaluated using chi-square tests and multivariable logistic regression models. Statistical significance was set at p < 0.05. Results: Overall, 38.10% of HCWs with complete ISI data had insomnia symptoms based on the predefined ISI ≥ 10 threshold. In multivariable analysis, Kazakh nationality (AOR = 2.11, 95% CI: 1.05–4.23), advanced education (AOR = 2.03, 95% CI: 1.13–3.65), physician role (AOR = 4.92, 95% CI: 1.25–19.30), and working with COVID-19 patients for >1 year (AOR = 2.28, 95% CI: 1.33–3.89) were significantly associated with increased odds of insomnia. Conclusions: Insomnia symptoms were common among surveyed HCWs during the COVID-19 pandemic and were associated with selected demographic and occupational characteristics, including professional role, education level, and duration of work with COVID-19 patients. These findings highlight the need for targeted mental health interventions and structural support systems for HCWs in Kazakhstan.

  • Open Access

    A meta-analysis of Preclinical Studies About The Effect of Spray-dried Porcine Plasma on Microbiota Composition

    by Momunova Aigul Abdykerimovna, Fakher Rahim, Lyailya Alekesheva, Toguzbaeva Karlygash, Sokolov Dmitriy Konstantinovich, Kenesh Dzhusupov, Abzal Zhumagaliuly

    Microorganisms in the gut microbiota have developed alongside the host for thousands of years. Spray-dried porcine plasma (SDPP) increases development and immunity, making it a promising antibiotic replacement. In this systematic review and meta-analysis, we examined all available data on spray-dried porcine plasma’s immune response and microbiota composition alterations, which may affect antibacterial effectiveness. To achieve this goal, Cochrane central, ISI web of science (WOS), PubMed/Medline, Scopus, and EMBASE were systematically searched using standard terms. No language, study region, or research kind restrictions applied. Following the exclusion criteria, this meta-analysis included 11 papers on 474 animals’ important traits. Eleven studies involved 474 animals in this meta-analysis. The study involved eight pigs, three mice, one dog, bird, and fish. Firmicutes, Bacteroidetes, and other bacteria were more prevalent in SDPP-fed pig samples than in control diet samples. Proteobacteria, Tenericutes, and Actinobacteria were less common in SDPP-fed pig samples. SDPP did not affect growth performance measures compared to the control group. SDPP-exposed animals had higher Shannon and Simpson indices and more species, regardless of BW. In addition, treatment groups had similar colonic microbiota richness estimators (Chao 1). This study represents the first comprehensive meta-analysis to investigate the impact of SDPP s on immune response and microbiota composition alterations, which may affect antibacterial effectiveness in the peer-reviewed literature. The study’s findings demonstrated that the utilization of SDPP imposes little residual effects on the overall growth performance and increases the diversity and richness of bacterial communities, ultimately leading to alterations in the microbiota composition of the animals.


  • Open Access

    Evaluating the Efficacy of Immunomodulatory Therapies in Rheumatoid Arthritis: A Clinical Study

    by Omorova Aizhan Nurlanovna, Zainab Sabah Kallow, Ihsan Khudhair Jasim, Omar Abdulwahid Salih Al-Ani, Ghanim Magbul, Abzal Zhumagaliuly

    Rheumatoid arthritis (RA) is a systemic autoimmune disorder driven by aberrant cytokine-mediated signalling that perpetuates synovial inflammation and joint destruction. Baricitinib, an oral Janus kinase-1/2 inhibitor, offers a mechanism-based therapeutic option; however, comparative data clarifying its broader immunomodulatory advantages remain limited. We conducted a 24-week, multicentre, double-blind, randomised controlled trial to compare the efficacy and safety of baricitinib with the tumour-necrosis-factor inhibitor adalimumab and with placebo in adults with moderate-to-severe RA who had an inadequate response to conventional synthetic DMARDs. Three hundred participants were allocated equally (1:1:1) to once-daily baricitinib 4 mg, subcutaneous adalimumab 40 mg every other week, or matched placebo, all on stable methotrexate. Co-primary endpoints were (i) mean change from baseline in the Disease Activity Score using 28 joints and C-reactive protein (DAS28-CRP) and (ii) the proportion of patients achieving clinical remission (DAS28-CRP < 2.6) at week 24. Secondary outcomes included the Health Assessment Questionnaire-Disability Index (HAQ-DI), 36-Item Short-Form Survey (SF-36), radiographic progression via modified Total Sharp Score (mTSS), and comprehensive safety assessments. Baricitinib achieved a greater DAS28 reduction (−3.3 ± 0.9) than adalimumab (−2.9 ± 0.8) and placebo (−1.5 ± 0.7), with remission rates of 50%, 45%, and 20%, respectively. Baricitinib also produced superior improvements in HAQ-DI and SF-36 and curtailed radiographic progression versus placebo. Adverse events—predominantly mild upper-respiratory infections—were more frequent with baricitinib, yet serious events were comparable across groups.

  • IMPLEMENTATION OF CHIMERIC ANTIGEN RECEPTOR (CAR)-T THERAPY FOR HEMATOLOGICAL MALIGNANCIES INTO PRACTICAL HEALTHCARE: A SYSTEMATIC REVIEW

    by A. Zhumagaliuly, A. Shustov, D. Menlayakova, S. Tanabayeva

    Chimeric antigen receptor T-cell (CAR-T) therapy represents a transformative advancement in the treatment of relapsed or refractory hematological malignancies such as leukemias, lymphomas, and multiple myeloma. Despite its remarkable efficacy in clinical trials, challenges remain in integrating CAR-T into routine healthcare systems. This systematic review examines key aspects of CAR-T implementation, including manufacturing logistics, economic evaluations, infrastructural readiness, regulatory frameworks, patient-reported outcomes (PROMs), and long-term follow-up strategies. Data from 25 studies highlight that while CAR-T has shown significant therapeutic potential, logistical barriers such as lengthy production timelines and specialized facility requirements hinder its scalability. Economic analyses reveal high upfront costs, with limited accessibility in low-resource settings. PROM data emphasize meaningful improvements in patient quality of life, though these findings are predominantly short-term. Adverse events, including cytokine release syndrome and neurotoxicity, necessitate rigorous safety protocols and specialized care teams. Long-term follow-up remains underexplored, with few studies providing insights into survivorship care. To address these challenges, the review identifies potential solutions, including decentralized manufacturing, innovative reimbursement models, and enhanced patient selection criteria. Collaborative efforts between stakeholders, robust policy frameworks, and patient-centered approaches are crucial for successful CAR-T integration. Future research should focus on longitudinal studies, real-world applications, and tailored survivorship protocols to optimize CAR-T delivery and outcomes. Чимериялық антигенді рецепторлы Т-жасушалық (CAR-T) терапия рецидивті немесе рефрактерлі гематологиялық қатерлі ісіктерді, мысалы, лейкемия, лимфома және көптеген миелома ауруларын емдеудегі революциялық жетістік болып табылады. Клиникалық зерттеулердегі жоғары тиімділігіне қарамастан, CAR-T терапиясын күнделікті денсаулық сақтау жүйелеріне енгізуде әлі де көптеген қиындықтар бар. Бұл жүйелік шолу CAR-T терапиясын енгізудің негізгі аспектілерін қарастырады, соның ішінде өндірісті ұйымдастыру логистикасы, экономикалық бағалау, инфрақұрылымдық дайындық, реттеуші негіздер, пациенттердің пікірлеріне негізделген нәтижелер (PROMs) және ұзақ мерзімді бақылау стратегиялары. 25 зерттеудің деректері CAR-T терапиясының терапевтік әлеуетінің жоғары екенін көрсеткенімен, ұзақ өндіріс уақыты мен арнайы жабдықталған мекемелерге қажеттілік сияқты логистикалық кедергілер оның кең көлемде қолданылуын тежейді. Экономикалық талдаулар жоғары бастапқы шығындарды және төмен ресурстық жағдайларда қолжетімділіктің шектеулігін көрсетеді. PROM деректері пациенттердің өмір сапасының елеулі жақсаруын көрсетеді, бірақ бұл деректер негізінен қысқа мерзімді болып табылады. Цитокиндердің босап шығу синдромы мен нейроуыттылық сияқты жағымсыз әсерлер қатаң қауіпсіздік хаттамаларын және арнайы дайындалған медициналық топтарды талап етеді. Ұзақ мерзімді бақылау аз зерттелген, және тірі қалған пациенттерді күту бойынша бірнеше зерттеу жүргізілген. Бұл қиындықтарды жеңу үшін шолу әлеуетті шешімдерді ұсынады, олардың ішінде децентрализденген өндіріс, инновациялық өтеу үлгілері және пациенттерді таңдау критерийлерін жетілдіру бар. Мүдделі тараптардың ынтымақтастығы, сенімді саясат негіздері және пациентке бағытталған тәсілдер CAR-T терапиясын табысты енгізу үшін өте маңызды. Болашақ зерттеулер ұзақ мерзімді зерттеулерге, нақты тәжірибелерге және тірі қалған пациенттерге арналған бейімделген хаттамаларға назар аударуы керек. Терапия с использованием Т-лимфоцитов с химерным антигенным рецептором (CAR-T) является революционным прорывом в лечении рецидивирующих или рефрактерных гематологических злокачественных новообразований, таких как лейкемия, лимфома и множественная миелома. Несмотря на высокую эффективность в рамках клинических исследований, существуют значительные трудности в интеграции CAR-T...

  • Open Access

    MENTAL HEALTH OF MEDICAL WORKERS DURING COVID-19 PANDEMIC: A LITERATURE REVIEW

    by Aryntayeva N.E., Griffin I., Koru-Sengul T., Aimbetova G.е., Baisugurova V.U., Bagiyarova F.A., Zhumagaliuly A.

    Background. Medical workers at hospitals who were directly involved in the diagnosis, treatment, and care of Covid-19 infected patients were at high risk of developing mental distress and other psychological health symptoms. The daily number of increased confirmed and suspected cases, stressful workload, lack of personal protection equipment and specific drugs, and adequate support led to the mental crisis of these healthcare workers. Aim. To promote and maintain the mental health of medical workers, we aimed to evaluate the psychological symptoms of healthcare workers during the Covid-19pandemic. The research method. To analyze and evaluate the mental health of healthcare workers during the Covid-19 pandemic PubMed, Google Scholar, Web of Science, MEDLINE Complete, and Cochrane Library databases were used for the period of 2020 to 2023. Studies conducted on healthcare workers working during the COVID-19 pandemic, including physicians, paramedics, nurses, and other medical workers; cross-sectional studies, cohort studies, and case-control studies published in the English language were included for this study. Key terms used for this review include “healthcare workers” or “health care provider” or “medical workers” or “front line workers” or “professionals” or “nurses” or “doctor” and “mental health” or “mental disorder” or “mental illness” or “mental health status” or “psychiatric illness” and “Covid-19” or “coronavirus disease 2019” or “SARS-CoV-2” or “coronavirus disease”. Exclusion criteria: studies conducted with healthcare professionals outside of COVID-19, evidence-based medicine articles with clear conclusions, articles published in other languages. As a result 25 articles were selected for this review. Conclusions. Covid-19 had a negative impact on the mental status of healthcare workers, especially frontline ones. Many studies showed that healthcare workers experienced symptoms of anxiety, depression, and insomnia during the COVID-19 pandemic and a lack of psychological services. Further strategies should address special interventions for screening and promoting the mental health of medical workers exposed to Covid-19. Актуальность. Медицинские работники больниц, которые непосредственно участвовали в диагностике, лечении и уходе за пациентами, инфицированными Covid-19, подвергались высокому риску развития психического расстройства и других симптомов ментального здоровья. Ежедневное увеличение числа подтвержденных и подозреваемых случаев, напряженная рабочая нагрузка, отсутствие средств индивидуальной защиты и специфических лекарств, а также адекватной поддержки — все это приводит ментальному кризису медицинских работников. Цель: Провести анализ источников по вопросу оценки ментального здоровья медицинских работников для укрепления и поддержания ментального здоровья медицинских работников во время пандемии Covid-19. Стратегия поиска. Для поиска информации по анализу и оценке ментального здоровья медицинских работников во время пандемии Covid-19 были использованы базы данных PubMed, Google Scholar, Web of Science, MEDLINE Complete и Cochrane Library за период с 2020 по 2023 год. Критерии включения в обзор: исследования, проведенные с участием медицинских работников, работавших во время пандемии COVID-19, включая врачей, фельдшеров, медсестер и других медицинских работников; перекрестные, когортные и исследования “случай-контроль”, опубликованные на английском языкe. Ключевые термины: “медицинские работники” или “медицинские работники передовой линии”, или “профессионалы”, или “медсестры”, или “врач”, и “психическое здоровье”, или “психическое расстройство”, или “ ментальное здоровье”, или “состояние психического здоровья” или “психическое заболевание” и “Covid-19”, или “коронавирусная болезнь 2019”, или “SARS-CoV-2”, или “коронавирусная болезнь”. Критерии исключения:исследования, проведенные с участием медицинских работников, не во время COVID-19, статьи, выдержанные в рамках доказательной медицины, с четкими выводами, статьи, опубликованные на других языках. В результате, для этого обзора было отобрано 25 статей. Выводы. Covid-19 оказал негативное влияние на ментальное здоровье медицинских работников, в частности кто работал напрямую с пациентами с подтвержденным...

  • Open Access

    Neuropsychological Assessment of Community-Dwelling Older Adults in Almaty, Kazakhstan

    by Mukhtar Kulimbet, Natalya Glushkova, Beth Snitz, Radmila Tsoy, Shalkar Adambekov, Evelyn Talbott, Alibek Mereke, Minjie Wu, Abzal Zhumagaliuly, Ferhat Karaca, et al.

    Cognitive impairment in older adults is a major public concern for Kazakhstan’s aging population. We aimed to (1) administer a neuropsychological test battery (NTB) in domains relevant to aging-associated cognitive impairment in a sample of adults aged 60+ without dementia in Almaty, Kazakhstan; (2) investigate the associations between demographic factors and test performance; and (3) provide information on the distribution of NTB scores as preliminary local normative data relevant for this population. A cross-sectional evaluation of 276 participants aged 60+ in Almaty, Kazakhstan, was conducted using cognitive instruments including tests of memory, attention, language, executive functions, visuospatial abilities, and processing speed. Multiple linear regression analyses were used to examine the association of demographic factors with neuropsychological test performance. The results from the regression analysis showed that those who are younger, have more years of education, are women, and are of Russian ethnicity had significantly better performance. The current study illustrated (1) the feasibility of administering the NTB to older adults in the general population in Kazakhstan; (2) the preliminary local normative neuropsychological measures; and (3) their independent associations with age, education, gender, and ethnicity. The findings are a platform for future research on dementia and cognitive impairment in older adults in Kazakhstan.